---
$id: https://graph.org.ai/products/commodity/51241224
$type: Product
source: UNSPSC
code: "51241224"
title: "Anthralin or dithranol"
class: "51241200"
classTitle: "Dermatologic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Anthralin or dithranol

**UNSPSC Code**: 51241224
**Class**: [Dermatologic agents](Dermatologic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-psoriatic agent with the molecular formula C14H10O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U8CJK0JH5M, chemically known as 1,8,9-anthracenetriol but generally known as anthralin, which bears US NIH Compound Identifier 2202. Anthralin most often comes in base and triacetate forms. European Medicines Agency schedules Dithranol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06332MIG. The term DITHRANOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules anthralin in its Anatomical Therapeutic Chemical (ATC) Classification. Anthralin or dithranol bears US NLM identifiers UMLS ID C0003166 and NCI Concept Code C28827. SMILES: O=C1C2C(CC3C1C(O)CCC3)CCCC2O.

